Today's Spotlight

Don’t Bet on Red

I have a new spectral-domain optical coherence tomographer (SD-OCT) that I used to perform an optic nerve evaluation on a patient. The test shows a very thin nerve fiber layer (NFL) and ganglion cell layer thinning. The patient has para-nasal visual field defects in both eyes. Her discs look normal, her IOP is 15mm HG OU and there is no family history of glaucoma. Is this low-tension glaucoma?  

Today's Spotlight

Let the Truth Set You Free

We refract in search of the truth, or at least something that makes the patient see better.

Today's Spotlight

New Meds: Today and Tomorrow

Today’s ODs have a robust armamentarium for treating just about anything that walks through the door, from the ubiquitous red eye to more nuanced conditions such as dry eye and glaucoma. Here’s a preview of what’s coming.

Today's Spotlight

In Between Days

I started covering optometry way back in 1991. Then, authors had to mail in their articles on floppy discs and we would send them edits on a new high-tech device called a fax machine. That feels like a prehistoric time compared to now. Also, so much has changed clinically since then that it’s practically a brand-new profession. But one thing hasn’t changed: the way scope of practice expansion efforts play out. 

Today's Spotlight

A Light in the DARC: Seeing Glaucoma Before it Strikes

It is common to detect retinal neurodegeneration only after extensive RGC death and significant visual loss have already occurred. Given the primacy of RGCs in glaucoma’s story, our research team has been working on a promising new diagnostic approach to improve early diagnosis that detects glaucomatous changes at a cellular level. 

Mar 18
Mar 17
Mar 16
Mar 15
Mar 14

The News Feed

Look Inside The Current Issue

March 15, 2019


Anti-VEGF: Where Are We Now?

This review looks into the years of research on this versatile class of medications and turns an eye to its future.

Can You Spot These Retinal Vascular Abnormalities?

Abnormal changes in the retinal vasculature are closely linked with underlying systemic conditions—impacting both the physical and ocular health of the patient.

Dry Eye Drugs: New Approaches to an Old Problem

Its multifactoral and variable nature makes DED a challenging condition to manage. These novel therapeutics are here to help.

My Patient Has Glaucoma...Now What?

After a clinical examination and testing, your diagnosis is confirmed. Now, it’s time to develop a management plan. Here’s how.

Red Eye Roundup

This symptom could be a harbinger of many conditions. Here’s a look at the common causes and what to do about them.

The Changing Landscape of Glaucoma Therapy

The future looks promising with the recent introduction of new treatment options.


A Diagnosis for the Birds

How can this patient’s presentation and MRI explain his vision loss?

A Stroke of Bad Luck

By the time you see this, it may be too late to save vision, but your responsibility doesn’t end there.

Beware the Red Herring LEMS

Lambert-Eaton myasthenic syndrome may present similarly to other neurological diseases.

CMV: Old Foe, New Victims

Immunocompromised patients aren’t the only ones at risk from cytomegalovirus.

Don’t Bet on Red

Know how to use OCT data to decide whether a patient truly has glaucoma.

Glaucoma Tools: Know the New Codes

Increased use of new diagnostic technology led to changes that impact your workup.

In Between Days

The defeat of the Arkansas expansion bill is more a delay of the inevitable rather than an outright failure.

Let the Truth Set You Free

Quit worrying about number one or number two. We have bigger truths to face, like that golf shirt you are wearing.

New Meds: Today and Tomorrow

Our pharmaceutical toolbox is practically bursting at the seams these days.

RPE: The Multitasking Master

This simple structure is crucial for maintaining visual function in more ways than one.

The Skinny on Peculiar Skin

A 67-year-old black female reported to the office with a chief complaint of blurry vision at near, as well as facial skin lesions. She asked if there was any medication that could improve her skin cosmesis.

Twice the Conditions, Twice the Fun

While the presence of other corneal abnormalities makes things difficult for this keratoconus patient, CXL should be initiated as soon as disease progression is detected.


Practice Pearls

Expert clinician Paul Karpecki, OD, provides practical insights and management strategies for a wide array of ocular conditions.

Optometric Retina Society E-Newsletter

Keep up to date on the latest research and clinical findings in retinal disease care with this quarterly publication from the ORS.

Optometric Physician E-Journal

A weekly e-journal edited by Art Epstein, OD, featuring incisive commentary, timely research summaries and late-breaking news.

Continuing Education

February 2019 • 2.00 Credits

Take a Clinical Approach to Anterior Uveitis

November 2018 • 2.00 Credits

Dry Eye Disease: Know Your Comorbidities

October 2018 • 2.00 Credits

The ABCs of Radiologic Testing


Jobs Powered By Local Eye Site

Review of Cornea & Contact Lenses

March/April 2019

Women in Optometry

Women in Optometry - November 2018